Table of Contents:
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of Asia Pacific Market by Product 43
3.1 Market Overview by Product 43
3.2 Instruments & Devices 45
3.2.1 Disposable IVD Devices 46
3.2.2 Reusable IVD Devices 47
3.3 Reagents & Kits 48
3.4 Software & Services 49
4 Segmentation of Asia Pacific Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Clinical Chemistry 52
4.3 Molecular Diagnostics 53
4.4 Immuno Diagnostics 54
4.5 Hematology 55
4.6 Tissue Diagnostics 56
4.7 Microbiology 57
4.8 Coagulation and Hemostasis 58
4.9 Urinalysis 59
4.10 Other Technologies 60
5 Segmentation of Asia Pacific Market by Sample Type 61
5.1 Market Overview by Sample Type 61
5.2 Blood 63
5.3 Mucus 64
5.4 Urine 65
5.5 Other Sample Types 66
6 Segmentation of Asia Pacific Market by Application 67
6.1 Market Overview by Application 67
6.2 Infectious Diseases 69
6.3 Diabetes 79
6.4 Cancer/Oncology 80
6.5 Cardiology 81
6.6 Autoimmune Disease 82
6.7 Nephrology 83
6.8 Drug Testing 84
6.9 HIV/AIDS 85
6.10 Other Applications 86
7 Segmentation of Asia Pacific Market by End User 87
7.1 Market Overview by End User 87
7.2 Diagnostic Laboratories 89
7.3 Hospitals and Clinics 90
7.4 Homecare Settings 91
7.5 Point-of-Care (POC) Settings 92
7.6 Other End Users 93
8 Asia-Pacific Market 2021-2031 by Country 94
8.1 Overview of Asia-Pacific Market 94
8.2 Japan 97
8.3 China 100
8.4 Australia 102
8.5 India 104
8.6 South Korea 106
8.7 Rest of APAC Region 108
9 Competitive Landscape 110
9.1 Overview of Key Vendors 110
9.2 New Product Launch, Partnership, Investment, and M&A 113
9.3 Company Profiles 114
Abbott Laboratories, Inc. 114
Agilent Technologies, Inc. 116
Arkray Inc. 117
Becton, Dickinson and Company 118
Biomerieux SA 119
Bio-Rad Laboratories Inc. 120
Danaher Corporation 121
DiaSorin SpA (Luminex Corporation) 122
Epic Systems Corporation 123
F. Hoffmann-La Roche Ltd. 124
Genpact Limited 125
Grifols SA 126
IBM Corporation 127
Mckesson Corporation 128
Ortho Clinical Diagnostics Inc. 129
Qiagen NV 130
Quest Diagnostics Inc. 131
Quidel Corporation 132
Roche Diagnostics 133
Siemens Healthineers 134
Sysmex Corporation 135
Thermo Fisher Scientific Inc. 136
RELATED REPORTS 137

List of Tables:

Table 1.  Snapshot of Asia Pacific In Vitro Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5.  Main Product Trends and Market Opportunities in Asia Pacific In Vitro Diagnostics Market 35
Table 6. Asia Pacific In Vitro Diagnostics Market by Product, 2021-2031, $ mn 43
Table 7. Asia Pacific In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn 45
Table 8. Asia Pacific In Vitro Diagnostics Market by Technology, 2021-2031, $ mn 50
Table 9. Asia Pacific In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn 61
Table 10. Asia Pacific In Vitro Diagnostics Market by Application, 2021-2031, $ mn 67
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-2022 70
Table 12. Asia Pacific In Vitro Diagnostics Market by End User, 2021-2031, $ mn 87
Table 13. APAC In Vitro Diagnostics Market by Country, 2021-2031, $ mn 95
Table 14. Japan In Vitro Diagnostics Market by Product, 2021-2031, $ mn 99
Table 15. Japan In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 99
Table 16. Japan In Vitro Diagnostics Market by End User, 2021-2031, $ mn 99
Table 17. China In Vitro Diagnostics Market by Product, 2021-2031, $ mn 101
Table 18. China In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 101
Table 19. China In Vitro Diagnostics Market by End User, 2021-2031, $ mn 101
Table 20. Australia In Vitro Diagnostics Market by Product, 2021-2031, $ mn 103
Table 21. Australia In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 103
Table 22. Australia In Vitro Diagnostics Market by End User, 2021-2031, $ mn 103
Table 23. India In Vitro Diagnostics Market by Product, 2021-2031, $ mn 105
Table 24. India In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 105
Table 25. India In Vitro Diagnostics Market by End User, 2021-2031, $ mn 105
Table 26. South Korea In Vitro Diagnostics Market by Product, 2021-2031, $ mn 107
Table 27. South Korea In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 107
Table 28. South Korea In Vitro Diagnostics Market by End User, 2021-2031, $ mn 107
Table 29. In Vitro Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 109
Table 30. Abbott Laboratories, Inc.: Company Snapshot 114
Table 31. Abbott Laboratories, Inc.: Business Segmentation 115
Table 32. Abbott Laboratories, Inc.: Product Portfolio 115

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Asia Pacific In Vitro Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Asia Pacific In Vitro Diagnostics Market 26
Figure 7.  Leading Causes of Death in the World, 2000 and 2019, million 29
Figure 8.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of Asia Pacific In Vitro Diagnostics Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific In Vitro Diagnostics Market 39
Figure 13. Breakdown of Asia Pacific In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue 44
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 44
Figure 15. Asia Pacific In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn 45
Figure 16. Asia Pacific In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn 46
Figure 17. Asia Pacific In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn 47
Figure 18. Asia Pacific In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn 48
Figure 19. Asia Pacific In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 49
Figure 20. Breakdown of Asia Pacific In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 21. Asia Pacific Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 22. Asia Pacific In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn 52
Figure 23. Asia Pacific In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn 53
Figure 24. Asia Pacific In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn 54
Figure 25. Asia Pacific In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn 55
Figure 26. Asia Pacific In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn 56
Figure 27. Asia Pacific In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn 57
Figure 28. Asia Pacific In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn 58
Figure 29. Asia Pacific In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn 59
Figure 30. Asia Pacific In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn 60
Figure 31. Breakdown of Asia Pacific In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue 62
Figure 32. Asia Pacific Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 62
Figure 33. Asia Pacific In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn 63
Figure 34. Asia Pacific In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn 64
Figure 35. Asia Pacific In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn 65
Figure 36. Asia Pacific In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn 66
Figure 37. Breakdown of Asia Pacific In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue 68
Figure 38. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 68
Figure 39. Asia Pacific In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn 69
Figure 40. Asia Pacific In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn 79
Figure 41. Asia Pacific In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn 80
Figure 42. Asia Pacific In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn 81
Figure 43. Asia Pacific In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn 82
Figure 44. Asia Pacific In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn 83
Figure 45. Asia Pacific In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn 84
Figure 46. Asia Pacific In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn 85
Figure 47. Asia Pacific In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 86
Figure 48. Breakdown of Asia Pacific In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue 88
Figure 49. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 88
Figure 50. Asia Pacific In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 89
Figure 51. Asia Pacific In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn 90
Figure 52. Asia Pacific In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn 91
Figure 53. Asia Pacific In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn 92
Figure 54. Asia Pacific In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 93
Figure 55. Breakdown of APAC In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 95
Figure 56. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 96
Figure 57.  In Vitro Diagnostics Market in Japan, 2021-2031, $ mn 98
Figure 58.  In Vitro Diagnostics Market in China, 2021-2031, $ mn 100
Figure 59.  In Vitro Diagnostics Market in Australia, 2021-2031, $ mn 102
Figure 60.  In Vitro Diagnostics Market in India, 2021-2031, $ mn 104
Figure 61.  In Vitro Diagnostics Market in South Korea, 2021-2031, $ mn 106
Figure 62.  In Vitro Diagnostics Market in Rest of APAC, 2021-2031, $ mn 108
Figure 63. Growth Stage of Asia Pacific In Vitro Diagnostics Industry over the Forecast Period 110

Selected Key Players: 
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)